Work

Real-world outcomes of Budesonide/Glycopyrronium/Formoterol therapy in COPD after 12 months; the RECORD study

Year: 2025

Type: conference-abstract

Source: European Respiratory Journal

DOI: 10.1183/13993003.congress-2025.pa5697

Authors: Henrik Watz, Marija Halbach, Matthias Saathoff, Tamsin Morris, Michael Watt, Annika Fernandez Milano, Dinesh Shrikrishna, Dave Singh

Institutions: AstraZeneca (United Kingdom), Musgrove Park Hospital, Taunton & Somerset NHS Foundation Trust, Somerset NHS Foundation Trust, University of Manchester

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4416639286

Cites:

Cited by:

Related to: 10